45 St. Clair Ave. West, Suite 600
Toronto, Ontario, M4V 1K9
Tel: (416) 925-7400

New York Times: Groundbreaking Study in Colombia Seeks Prevention for Alzheimer’s Disease

On May 16, 2012, the New York Times reported on a unique study being conducted to test for possible prevention for Alzheimer’s disease. The study is being conducted on 300 members of an extended family from Medellin, Colombia, who exhibit a genetic mutation that leads to a high incidence of Alzheimer’s and dementia, often with early onset. The study aims to examine whether the proposed drug, Crenezumab, can delay memory decline or brain changes and focuses on prevention by administering the drug prior to the onset of any symptoms. The study could have a wide-ranging impact on those affected by Alzheimer’s, and for members of this Colombian family deeply affected by Alzheimer’s, it offers them a glimmer of hope.

Click here to read the New York Times article.

Click here to read the New York Times “Vanishing Mind” series, which examines the global struggle to seek answers about Alzheimer’s disease.


Previous Post:
Next Post:
Click here or on top Blog logo to return to Blog front page.

Search Blog by Keyword(s)

Site Search

Site Map